The Easy Prescription

After my divorce, the practical disasters came fast — no home, no job, a custody case that dragged on long after the rest was fixed. I solved the housing. I solved the job. The court case just sat there, month after month, a low hum of stress I couldn't close the file on. Eventually my body answered for me: I couldn't keep food down. The smallest stress and it came back up. I went to my GP for help. Her only answer was antidepressants. I never took them. What actually worked was breathing exercises — retraining a nervous system stuck in high alert. No prescription required. I've since wondered how often that exact exchange happens: a doctor with nine minutes and one tool, offering the tool instead of asking what's actually wrong.

It's Not Just Me

A mental-health presentation gets, on average, half a minute more than any other kind of appointment. The British Medical Association and the Royal College of GPs have both said publicly that ten-minute slots aren't enough for real complexity — and one study found that extending consultations to thirty minutes was more cost-effective than many of the drugs prescribed in the ten-minute version, with patients measurably better off a year later. In one primary-care study of first-episode depression, nearly 44% of referrals to a specialist carried no documented clinical justification at all. Not wrong, necessarily. Just not reasoned through — closer to a coin flip than a diagnosis.

None of this means antidepressants or painkillers are illegitimate. It means the fastest tool in the room gets reached for before the slower, better one — a diagnosis, a referral, a lifestyle intervention — gets a fair look. What follows is what the actual published evidence says about both drug classes, and what a terrain-level alternative looks like for the two problems they're most often used to solve.

What the Antidepressant Data Actually Shows

A widely shared Mad in America article this month claimed antidepressants can "change peaceful citizens into killers," built on a real 2015 Finnish study of 959 convicted murderers (Tiihonen et al., World Psychiatry) that found a 31% higher homicide risk associated with antidepressant prescriptions. That number is real. What the article didn't mention is what else was in the same study.

Two large Swedish registry studies since (Molero 2015, Lagerberg 2020 — over 850,000 patients combined) looked for the same antidepressant-violence link. Where they found anything, it was almost entirely confined to patients under 25, with no clear dose-response relationship, and the authors' own conclusion was blunt: the association "cannot be interpreted causally" — the depression itself, not the pill, is the more likely driver.

The one case where a jury did formally find a pharmaceutical company responsible is worth knowing, because it isn't the case most often cited.

The part of the antidepressant story that gets the least attention isn't violence — it's what happens when someone tries to stop.

The Painkiller Nobody Warns You About

Ordinary NSAIDs — ibuprofen, diclofenac, naproxen — carry the largest single risk signal in the Finnish homicide study above, at three times the antidepressant figure. The proposed mechanism is real pharmacology, not speculation: prostaglandins normally suppress dopamine release, and blocking that suppression can trigger a dopamine surge in sensitive individuals — documented, in rare cases, as paranoid psychosis. There's even a named clinical category for it: NSAID-induced Othello's syndrome, delusional jealousy severe enough to be genuinely dangerous. The strongest suspects aren't ordinary ibuprofen but indomethacin and selective COX-2 inhibitors specifically — chemically closer to serotonin in structure than the more common NSAID classes, which likely explains why the effect doesn't generalize evenly across the drug class.

That's the rare, dramatic risk. The common, quiet one is older and much larger in scale.

What's Actually Driving This

The "low serotonin causes depression" story that most people were taught is not what the evidence supports. A 2022 umbrella review found no consistent evidence for it across six major lines of research — contested by other psychiatrists on methodology, but consistent with what specialists had already suspected for years: SSRIs can work without the original theory being correct. The more defensible picture that's replaced it isn't simpler, but it is more useful, because it points to things you can actually address.

The Terrain Response

Both problems already have a botanical answer on this site — not a new idea, just laid out with the same evidence grading as everything above.

The thread connecting all of it back to my own story is the vagus nerve — the same route breathing exercises use. Fiber intake feeds it via short-chain fatty acids; hop bitter acids activate it directly; and it's the reason a non-pharmacological intervention was able to do, for me, what a prescription pad was the only thing offered.

The Sovereign Position

None of this argues against medication ever. Extreme, acute crises deserve fast, effective tools, and sometimes a pill is exactly the right one. What it argues against is the pill being the only tool offered inside a nine-minute window — before cortisol is checked, before inflammation is checked, before anyone asks what's actually driving the number on the chart. A prescription is fast. A diagnosis takes longer. The evidence above says the difference between those two things is not a technicality.